These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

798 related articles for article (PubMed ID: 20845002)

  • 1. Efficacy and safety of flavocoxid, a novel therapeutic, compared with naproxen: a randomized multicenter controlled trial in subjects with osteoarthritis of the knee.
    Levy RM; Khokhlov A; Kopenkin S; Bart B; Ermolova T; Kantemirova R; Mazurov V; Bell M; Caldron P; Pillai L; Burnett BP
    Adv Ther; 2010 Oct; 27(10):731-42. PubMed ID: 20845002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavocoxid is as effective as naproxen for managing the signs and symptoms of osteoarthritis of the knee in humans: a short-term randomized, double-blind pilot study.
    Levy RM; Saikovsky R; Shmidt E; Khokhlov A; Burnett BP
    Nutr Res; 2009 May; 29(5):298-304. PubMed ID: 19555810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of flavocoxid compared with naproxen in subjects with osteoarthritis of the knee- a subset analysis.
    Levy R; Khokhlov A; Kopenkin S; Bart B; Ermolova T; Kantemirova R; Mazurov V; Bell M; Caldron P; Pillai L; Burnett B
    Adv Ther; 2010 Dec; 27(12):953-62. PubMed ID: 20972845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost analysis of flavocoxid compared to naproxen for management of mild to moderate OA.
    Walton SM; Schumock GT; McLain DA
    Curr Med Res Opin; 2010 Sep; 26(9):2253-61. PubMed ID: 20690891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using the medical food flavocoxid [corrected] in managing osteoarthritis.
    Gottlieb D; Kuritzky L
    J Pain Palliat Care Pharmacother; 2011; 25(1):49-54. PubMed ID: 21426218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis.
    Lohmander LS; McKeith D; Svensson O; Malmenäs M; Bolin L; Kalla A; Genti G; Szechinski J; Ramos-Remus C;
    Ann Rheum Dis; 2005 Mar; 64(3):449-56. PubMed ID: 15345500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized placebo-controlled trial comparing efficacy and safety of valdecoxib with naproxen in patients with osteoarthritis.
    Kivitz A; Eisen G; Zhao WW; Bevirt T; Recker DP
    J Fam Pract; 2002 Jun; 51(6):530-7. PubMed ID: 12100776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GOAL: multicenter, open-label, post-marketing study of flavocoxid, a novel dual pathway inhibitor anti-inflammatory agent of botanical origin.
    Pillai L; Burnett BP; Levy RM;
    Curr Med Res Opin; 2010 May; 26(5):1055-63. PubMed ID: 20225990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
    Temple AR; Benson GD; Zinsenheim JR; Schweinle JE
    Clin Ther; 2006 Feb; 28(2):222-35. PubMed ID: 16678643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, crossover comparative endoscopy study on the gastroduodenal tolerability of a highly specific cyclooxygenase-2 inhibitor, flosulide, and naproxen.
    Bjarnason I; Macpherson A; Rotman H; Schupp J; Hayllar J
    Scand J Gastroenterol; 1997 Feb; 32(2):126-30. PubMed ID: 9051872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fixed-dose combination of naproxen and esomeprazole magnesium has comparable upper gastrointestinal tolerability to celecoxib in patients with osteoarthritis of the knee: results from two randomized, parallel-group, placebo-controlled trials.
    Cryer BL; Sostek MB; Fort JG; Svensson O; Hwang C; Hochberg MC
    Ann Med; 2011 Dec; 43(8):594-605. PubMed ID: 22017620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the analgesic efficacy and safety of nonprescription doses of naproxen sodium and Ibuprofen in the treatment of osteoarthritis of the knee.
    Schiff M; Minic M
    J Rheumatol; 2004 Jul; 31(7):1373-83. PubMed ID: 15229960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind study comparing the long-term efficacy of the COX-2 inhibitor nimesulide and naproxen in patients with osteoarthritis.
    Kriegel W; Korff KJ; Ehrlich JC; Lehnhardt K; Macciocchi A; Moresino C; Pawlowski C
    Int J Clin Pract; 2001 Oct; 55(8):510-4. PubMed ID: 11695069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of naproxcinod in the treatment of patients with osteoarthritis of the knee: a 13-week prospective, randomized, multicenter study.
    Schnitzer TJ; Kivitz A; Frayssinet H; Duquesroix B
    Osteoarthritis Cartilage; 2010 May; 18(5):629-39. PubMed ID: 20202489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the COX-inhibiting nitric oxide donator AZD3582 and rofecoxib in treating the signs and symptoms of Osteoarthritis of the knee.
    Schnitzer TJ; Kivitz AJ; Lipetz RS; Sanders N; Hee A
    Arthritis Rheum; 2005 Dec; 53(6):827-37. PubMed ID: 16342089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of Naprelan and Naprosyn in the treatment of osteoarthritis of the knee.
    Schiff MH
    Am J Orthop (Belle Mead NJ); 1996 Sep; 25(9 Suppl):14-20. PubMed ID: 8886213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo.
    Bensen WG; Zhao SZ; Burke TA; Zabinski RA; Makuch RW; Maurath CJ; Agrawal NM; Geis GS
    J Rheumatol; 2000 Aug; 27(8):1876-83. PubMed ID: 10955327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis.
    Goldstein JL; Correa P; Zhao WW; Burr AM; Hubbard RC; Verburg KM; Geis GS
    Am J Gastroenterol; 2001 Apr; 96(4):1019-27. PubMed ID: 11316141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
    Goldstein JL; Cryer B; Amer F; Hunt B
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1167-74. PubMed ID: 17916545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study.
    Singh G; Fort JG; Goldstein JL; Levy RA; Hanrahan PS; Bello AE; Andrade-Ortega L; Wallemark C; Agrawal NM; Eisen GM; Stenson WF; Triadafilopoulos G;
    Am J Med; 2006 Mar; 119(3):255-66. PubMed ID: 16490472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.